TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 176 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $386,047 | -41.8% | 43,182 | 0.0% | 0.00% | – |
Q2 2023 | $663,275 | -31.7% | 43,182 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $971,163 | +78346.1% | 43,182 | -26.7% | 0.00% | 0.0% |
Q4 2022 | $1,238 | -99.9% | 58,873 | -11.3% | 0.00% | 0.0% |
Q3 2022 | $1,635,000 | +1.7% | 66,362 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,608,000 | -6.1% | 66,362 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $1,712,000 | +25.1% | 66,445 | +50.6% | 0.00% | 0.0% |
Q4 2021 | $1,369,000 | +100.4% | 44,118 | +56.6% | 0.00% | – |
Q3 2021 | $683,000 | +112.1% | 28,180 | +27.7% | 0.00% | – |
Q2 2021 | $322,000 | -41.6% | 22,070 | 0.0% | 0.00% | – |
Q1 2021 | $551,000 | -8.5% | 22,070 | 0.0% | 0.00% | – |
Q4 2020 | $602,000 | – | 22,070 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 875,221 | $19,683,720 | 7.52% |
Deep Track Capital, LP | 6,147,268 | $138,252,057 | 5.68% |
Kynam Capital Management, LP | 1,563,595 | $35,165,252 | 4.54% |
GREAT POINT PARTNERS LLC | 1,003,000 | $22,557,470 | 4.43% |
ARMISTICE CAPITAL, LLC | 7,148,000 | $160,758,520 | 2.32% |
HighVista Strategies LLC | 121,834 | $2,740,047 | 2.23% |
MPM BioImpact LLC | 313,642 | $7,053,809 | 1.83% |
Sofinnova Investments, Inc. | 1,263,721 | $28,421,085 | 1.82% |
Octagon Capital Advisors LP | 495,000 | $11,132,550 | 1.60% |
SECTORAL ASSET MANAGEMENT INC | 358,613 | $8,065,206 | 1.55% |